|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.28 USD | +0.16% |
|
+0.49% | +81.03% |
| Market Cap | 8.93B 7.73B 7.24B 6.61B 12.43B 851B 12.64B 84.9B 33.27B 426B 33.51B 32.78B 1,422B | P/E 2026 * |
-17.8x | P/E 2027 * | -20.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.89B 6.84B 6.4B 5.84B 10.99B 753B 11.18B 75.06B 29.41B 377B 29.63B 28.98B 1,257B | EV / Sales 2026 * |
134x | EV / Sales 2027 * | 46.8x |
| Free-Float |
98.25% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Crinetics Pharmaceuticals, Inc.
| 1 day | +0.16% | ||
| 1 week | +0.49% | ||
| Current month | +0.90% | ||
| 1 month | +0.72% | ||
| 3 months | +130.56% | ||
| 6 months | +77.00% | ||
| Current year | +81.03% |
| 1 week | 83.83 |  | 84.34 |
| 1 month | 83.47 | | 84.34 |
| Current year | 32.3 | | 84.34 |
| 1 year | 27.52 | | 84.34 |
| 3 years | 15.76 | | 84.34 |
| 5 years | 15.23 | | 84.34 |
| 10 years | 10.63 | | 84.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Struthers
CEO | Chief Executive Officer | 64 | 2008-11-30 |
Stephen Betz
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-09-30 |
Tobin Schilke
DFI | Director of Finance/CFO | 51 | 2025-02-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Wendell Wierenga
CHM | Chairman | 78 | 2015-09-30 |
R. Struthers
BRD | Director/Board Member | 64 | 2008-10-31 |
Matthew Fust
BRD | Director/Board Member | 61 | 2018-01-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/2/26 | Sell | Director | -3,000 | 0.0028% | ||
| 3/12/26 | Sell | Director | 5,000 | 0.0048% | ||
| 2/23/26 | Free | Chief Financial Officer | 82,000 | 0.0871% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | +0.49% | +207.78% | +410.26% | 8.93B | |
| -0.70% | +24.68% | +76.72% | +103.05% | 70.85B | |
| -2.35% | +2.88% | +35.39% | +64.72% | 55.41B | |
| -0.35% | +35.91% | +18.89% | +498.35% | 29.43B | |
| -0.30% | +18.51% | +56.61% | +4.86% | 24.12B | |
| -0.37% | +0.94% | -15.61% | -13.76% | 23.31B | |
| +0.05% | +6.12% | +46.81% | -21.81% | 18.37B | |
| +9.77% | +25.32% | +252.40% | +442.16% | 16.99B | |
| 0.00% | +10.84% | +31.14% | +628.97% | 16.1B | |
| -1.88% | -6.82% | +39.48% | +142.47% | 13.12B | |
| Average | +0.40% | +360.04% | +74.96% | +225.93% | 27.66B | |
| Weighted average by Cap. | -0.23% | +340.61% | +61.37% | +173.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.81M 50.97M 47.71M 43.54M 81.93M 5.61B 83.3M 559M 219M 2.81B 221M 216M 9.37B | 172M 149M 140M 127M 240M 16.42B 244M 1.64B 642M 8.22B 647M 632M 27.42B |
| Net income | -516M -448M -419M -382M -719M -49.26B -732M -4.91B -1.92B -24.66B -1.94B -1.9B -82.26B | -473M -410M -383M -350M -658M -45.07B -669M -4.5B -1.76B -22.56B -1.77B -1.74B -75.27B |
| Net Debt | -1.04B -897M -840M -766M -1.44B -98.72B -1.47B -9.85B -3.86B -49.41B -3.89B -3.8B -165B | -865M -750M -702M -640M -1.21B -82.52B -1.23B -8.23B -3.22B -41.3B -3.25B -3.18B -138B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | US$84.27 | +0.14% | 799,601 |
| 26-08-10 | US$84.15 | +0.08% | 2,330,195 |
| 26-08-07 | US$84.08 | +0.19% | 1,941,776 |
| 26-08-06 | US$83.92 | -0.10% | 2,096,262 |
| 26-08-05 | US$84.00 | +0.17% | 2,866,831 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
